Back to Home

finance

Finance

Victory Capital’s August AUM Growth: 5 Key Equity Insights

Explore how Victory Capital’s August 2025 AUM climbed 1.3%, driven by equity gains and strategic moves, revealing fresh perspectives on asset management and market positioning.

Sep 12, 2025Read →
Finance

NuScale Power vs. Nano Nuclear: Which Nuclear Stock Leads in 2025?

Explore how NuScale Power and Nano Nuclear Energy stack up in the evolving nuclear market, revealing key insights on their technology, financials, and growth potential for savvy investors eyeing nuclear stocks.

Sep 12, 2025Read →
Finance

Dell vs. APLD: Which AI Infrastructure Stock Wins in 2025?

Explore the 2025 AI infrastructure showdown between Dell Technologies and Applied Digital (APLD). Discover valuation gaps, growth drivers, and which stock suits your investment appetite in this booming sector.

Sep 12, 2025Read →
Finance

Novartis Acquisition Boosts Cardiovascular Pipeline with Pacibekitug

Explore how Novartis’s $1.4B acquisition of Tourmaline Bio adds the Phase III cardiovascular drug pacibekitug, targeting IL-6 inflammation to reshape heart disease treatment and pipeline growth.

Sep 10, 2025Read →
Finance

How Ford Pro’s ServiceTitan Deal Revolutionizes Fleet Management

Discover how Ford Pro’s partnership with ServiceTitan transforms fleet management by integrating real-time vehicle data with operations software, cutting downtime and boosting efficiency for trades businesses across North America.

Sep 10, 2025Read →
Finance

Unlocking Precision: Onto Innovation’s Atlas G6 Metrology Breakthrough

Discover how Onto Innovation’s Atlas G6 optical metrology system revolutionizes AI-era semiconductor process control with unmatched precision, smaller spot sizes, and faster optimization for next-gen chip manufacturing.

Sep 10, 2025Read →
Finance

Unlocking Quantum-Secure Data Transport: Ciena & REDIMadrid’s Breakthrough

Discover how Ciena and REDIMadrid’s quantum-secure data transport project revolutionizes network security by integrating Quantum Key Distribution with existing fiber, safeguarding AI-driven traffic and future-proofing Madrid’s research infrastructure.

Sep 10, 2025Read →
Finance

5 Large Drug Stocks to Watch Amid Pharma Industry Headwinds

Explore 5 large drug stocks showing resilience and innovation in 2025’s challenging pharma landscape, navigating patent cliffs, tariffs, and regulatory shifts with strategic pipelines and robust growth prospects.

Sep 10, 2025Read →
Finance

ION582 Breakthrough: Ionis Advances Angelman Syndrome Treatment

Discover how Ionis Pharmaceuticals’ ION582 earned FDA Breakthrough Therapy status, accelerating hope for Angelman syndrome patients with promising clinical gains and a competitive edge in rare neurological disease therapies.

Sep 10, 2025Read →